- Home
- MGIC vs INM Comparison
MGIC vs INM Comparison
Compare MGIC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- INM
- Stock Information
- Founded
- MGIC 1983
- INM 1981
- Country
- MGIC Israel
- INM Canada
- Employees
- MGIC N/A
- INM N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- INM Health Care
- Exchange
- MGIC Nasdaq
- INM Nasdaq
- Market Cap
- MGIC 990.3M
- INM 5.0M
- IPO Year
- MGIC 1991
- INM N/A
- Fundamental
- Price
- MGIC $20.25
- INM $2.07
- Analyst Decision
- MGIC Buy
- INM
- Analyst Count
- MGIC 2
- INM 0
- Target Price
- MGIC $18.00
- INM N/A
- AVG Volume (30 Days)
- MGIC 26.8K
- INM 114.1K
- Earning Date
- MGIC 11-17-2025
- INM 11-13-2025
- Dividend Yield
- MGIC 3.08%
- INM N/A
- EPS Growth
- MGIC 16.93
- INM N/A
- EPS
- MGIC 0.78
- INM N/A
- Revenue
- MGIC $584,528,000.00
- INM $4,942,633.00
- Revenue This Year
- MGIC $11.72
- INM N/A
- Revenue Next Year
- MGIC $6.24
- INM N/A
- P/E Ratio
- MGIC $25.78
- INM N/A
- Revenue Growth
- MGIC 11.98
- INM 7.50
- 52 Week Low
- MGIC $10.42
- INM $1.72
- 52 Week High
- MGIC $22.00
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- MGIC 50.21
- INM 42.37
- Support Level
- MGIC $19.38
- INM $2.04
- Resistance Level
- MGIC $21.00
- INM $2.26
- Average True Range (ATR)
- MGIC 0.49
- INM 0.14
- MACD
- MGIC -0.07
- INM -0.01
- Stochastic Oscillator
- MGIC 42.60
- INM 10.44
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.